Understanding the FDA's Revised General Wellness Policy for Low-Risk Devices in 2026

The FDA updated its General Wellness policy in January 2026, offering clearer guidance on how it regulates low-risk wellness products. This update affects manufacturers and developers of consumer wellness devices and software designed to promote healthy lifestyles without diagnosing or treating diseases. Understanding these changes is crucial for companies to avoid unnecessary regulatory burdens and for consumers to know what products fall under FDA oversight.

FDA's updated policy impacts wearable wellness devices

What the FDA’s General Wellness Policy Covers

The FDA’s Center for Devices and Radiological Health (CDRH) revised its policy to clarify which products qualify as low-risk wellness devices. These products are intended to support a healthy lifestyle and are not meant to diagnose, cure, mitigate, prevent, or treat any disease or medical condition.

The key points of the policy include:

• Scope of Low-Risk Devices: Products that encourage physical activity, healthy eating, relaxation, or sleep improvement without making medical claims.

• Software and Apps: Wellness software that helps users maintain or improve general health but does not provide medical advice or diagnosis.

• Exclusion from Device Definition: Such products fall outside the FDA’s definition of a medical device under section 201(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

  
  

This means many consumer wellness products can avoid the lengthy and costly FDA device approval process if they meet these criteria.

Why This Update Matters

The 2026 revision addresses confusion around which wellness products require FDA regulation. Before this update, some manufacturers faced uncertainty about whether their products needed to comply with medical device regulations. This could delay product launches and increase costs.

Now, the FDA provides clearer examples and criteria, helping manufacturers:

• Confirm Eligibility: Determine if their product qualifies as low-risk and is exempt from device regulations.

• Avoid Unnecessary Compliance: Save time and resources by not pursuing FDA device clearance when it’s not required.

• Focus on Innovation: Develop wellness products that support healthy habits without regulatory hurdles.

  
  

For consumers, this means easier access to a wider range of wellness products that are safe and designed for everyday health support.

Examples of Products Covered by the Policy

To illustrate, here are some typical products that fall under the updated General Wellness policy:

• Fitness Trackers: Devices that count steps, monitor heart rate, or track calories burned without diagnosing heart conditions.

• Meditation Apps: Software that guides relaxation and stress reduction without claiming to treat anxiety disorders.

• Sleep Monitors: Tools that track sleep patterns and suggest lifestyle changes but do not diagnose sleep apnea.

• Nutrition Trackers: Apps that help users log meals and encourage balanced diets without diagnosing nutritional deficiencies.

  
  

These products promote wellness but do not cross into medical device territory because they avoid disease-related claims.

What Manufacturers Should Do Next

Manufacturers of consumer wellness products should take these steps to align with the updated policy:

• Review Product Claims: Ensure marketing and labeling avoid medical claims related to diagnosis or treatment.

• Assess Product Functionality: Confirm the product’s intended use supports general wellness only.

• Document Compliance: Keep clear records showing how the product fits the low-risk category.

• Consult FDA Guidance: Use the updated policy documents and examples to guide product development and marketing.

  
  

If a product does not meet the low-risk criteria, manufacturers must prepare for FDA device regulation, including premarket submissions and quality system requirements.

Impact on Innovation and Consumer Health

By clarifying the boundaries of FDA regulation, the updated policy encourages innovation in the wellness space. Companies can focus on creating tools that help people improve their health habits without the fear of regulatory delays.

Consumers benefit from a broader selection of wellness products that are safe and designed to support healthy lifestyles. The policy also helps maintain FDA oversight where it matters most—on products that diagnose or treat medical conditions.